Erythromycin Thiocyanate Import Under Advance Authorisation Exempted from Drugs Registration

[DGFT Policy Circular No. 55 dated 29^th February 2012]

Subject: Conditionality for Import of Erythromycin Thiocyanate under Advance Authorization Scheme: Applicability of Policy Circular No.9 dated 30.6.2003 and PC 15 dated 17.9.2003.

Policy Circular No. 9 dated 30.6.2003 and Policy Circular No 15 dated 17.9.2003 prescribe exemption from the registration procedure for imports of approved and unapproved drugs under Advance Authorisation. The issue whether Erythromycin Thiocyanate falls under the purview of these Circulars or not, has been examined in consultation with the Drugs Controller General of India (DCGI).

2. It is hereby clarified that the import of Erythromycin Thiocyanate for manufacturing and export of ‘Erythromycin Salts’ under Advance Authorisation Scheme is exempt from the conditionalities imposed under Policy Circular No. 9 dated 30.6.2003 and Policy Circular No. 15 dated 17.9.2003. In such cases, only the normal conditions of Advance Authorisation will apply.

3. In case the import of Erythromycin Thiocyanate is for veterinary medicinal use or for manufacturing of any drug under Advance Authorisation, then the conditions of the Policy Circulars No. 9 dated 30.6.2003 and No. 15 dated 17.9.2003 shall apply, in addition to normal condition for all Advance Authorisations.

This issues with the approval of competent authority.